EMPEROR-Preserved: A new hope for Heart Failure with Prese | UPDATES IN MEDICINE
EMPEROR-Preserved: A new hope for Heart Failure with Preserved Ejection Fraction
● CONCLUSIONS - Empagliflozin reduced the combined risk of cardiovascular death or hospitalization for heart failure in patients with heart failure and a preserved ejection fraction, regardless of the presence or absence of diabetes.
